Close Menu

NEW YORK – NeoGenomics this week announced its intention to build a new cancer diagnostic testing facility and global business headquarters in Fort Myers, Florida. The new facility is expected to open in 2021. The 150,000-square-foot laboratory and headquarters will incorporate innovative technology for comprehensive cancer testing that spans all testing modalities, including a state-of-the-art molecular lab with next-generation sequencing technology, NeoGenomics said. The new lab will also support clinical trials for new oncology drugs.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.